Bio

Anthony Clare is a corporate partner specialising in M&A and corporate finance. He covers a range of sectors, with particular market recognition in life sciences and biotechnology. Anthony advises on a wide range of corporate matters including M&A (public and private), joint ventures and equity capital markets. He has acted on over 20 IPOs in the London market, with a particular bias towards issuer-side mandates. He is well known in the biotech industry and has served for over nine years on the board, and as Vice Chairman, of The Babraham Institute, Cambridge – one of Europe’s leading bioscience research institutes. Anthony is also a board trustee of the Institute of Cancer Research, one of the world's most influential cancer research institutions. Anthony is named as a 'star' in the corporate section of the 2015 edition of LMG Life Sciences and listed in the Top 50 European M&A lawyers 2014 by Global M&A Network (EMEA). "Anthony Clare … is particularly knowledgeable on biotech companies. He is well known in the sector for his record in M&A and venture capital deals"